skip to Main Content

Clinical Efficacy of Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Pancreatic carcinoma is the neoplasia with the major mortality, and main standard treatments in this cancer increase survival but do not lead to complete recovery of the patient.

The aim of this study was to evaluate the efficacy of Abraxane® (nab-paclitaxel) in Italian patients with metastatic pancreatic cancer (MPC). Read more . . . 

Back To Top